Cannabis use and markers of systemic inflammation: The Coronary Artery Risk Development in Young Adults Study
American Journal of Medicine Jul 18, 2019
Alshaarawy O, et al. - Via The Coronary Artery Risk Development in Young Adults study, a cohort of 5,115 African-American and Caucasian males and females were recruited in 1985-1986 and followed up for over 25 years, with recurring measurements of cannabis use, researchers investigated immunomodulation attributable to cannabis, as demonstrated in levels of fibrinogen, C-reactive protein (CRP), and interleukin-6. Current cannabis use had no correlation with any of the biomarkers studied, even after adjusting for potential confounding variables, vs never users. Previous cannabis use had an inverse correlation with fibrinogen levels; the correlations were smaller for serum CRP. A modest inverse correlation among previous cannabis use and fibrinogen was seen. In order to examine the immunomodulatory impacts of cannabis relative to various cannabis preparations and modes of use, more studies are required.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries